| INNATE PHARMA SP.ADR/1 |
| USA |
| Gesundheit |
| US45781K2042 / A2PSSH |
| IDDA (Frankfurt) / IPHA (NASDAQ) |
| FRA:IDDA, ETR:IDDA, IDDA:GR, NASDAQ:IPHA |
| - |
| https://www.innate-pharma.. |
|
Innate Pharma S.A. Sponsored ADR is a security that allows investors in the United States to gain exposure to Innate Pharma, a biotechnology company based in France. Innate Pharma focuses on developing innovative immunotherapies for cancer treatment...
>Volltext.. |
| 99.98 Mio. EUR |
| 88.06 Mio. EUR |
| 2.7 Mio. EUR |
| -57.55 Mio. EUR |
| -48.22 Mio. EUR |
| -0.54 EUR |
| 22.92 Mio. EUR |
| 28.53 Mio. EUR |
| -53.2 Mio. EUR |
| 0.94 |
| -77.09% |
| -4.22% |
| - |
| - |
| - |
| - |
| INNATE PHARMA ADR, INNATE PHARMA |
| 01.04.26 |
|